Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
55.50    -0.50 (-0.89%)
Bid:
55.00
Ask:
56.00
Spread: 1.00 (1.818%)
Market Cap: £8.45m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Total Voting Rights

31 May 2022 17:00

RNS Number : 2545N
Transense Technologies PLC
31 May 2022
 

31 May 2022

 

Transense Technologies plc

 ("Transense" or the "Company")

 

Total voting rights

 

Transense Technologies plc, the provider of specialist sensor systems, announces that the total number of voting rights in respect of each class of share in issue and admitted to trading on AIM at the date of this announcement is as follows:

Number of shares in issue

Number of voting rights

Ordinary shares of 10 pence each

16,437,740

16,003,740

 

As at the date of this announcement the Company held 434,000 Ordinary shares in Treasury.

 

 

The voting rights figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

· SAW , patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik , smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack , a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

For further information please contact transense@walbrookpr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRFZGFKGGZGZZM
Date   Source Headline
23rd Nov 20117:00 amRNSOtraco iTrack Trial
21st Nov 201110:00 amRNSProposed Fundraising - Replacement
21st Nov 20117:00 amRNSProposed Fundraising
20th Oct 20117:00 amRNSContract - Pirelli Brazil
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSNew Trading Division
27th Sep 20117:00 amRNSShare Allotment
26th Sep 20117:00 amRNSUpdate
16th Sep 20118:38 amRNSDirector/PDMR Shareholding
16th Aug 201111:32 amRNSJoint Development Agreement - McLaren Electronics
23rd Jun 20092:48 pmRNSDirector/PDMR Shareholding
8th Jun 20097:00 amRNSRe Translogik Limited
29th Apr 20091:08 pmRNSJt Development with McLaren Electronic Systems Ltd
7th Apr 20097:00 amRNSFinal Results
6th Mar 200911:18 amRNSNotice of Preliminary Results
4th Feb 20095:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20092:50 pmRNSGrant of Options
30th Jan 20092:37 pmRNSDirectorate Change
30th Jan 20091:47 pmRNSContract Win
12th Jan 20091:12 pmRNSHolding(s) in Company
22nd Dec 20083:33 pmRNSWaiver & Grant of New Options
12th Nov 200811:50 amRNSUpdate re Vectron International
21st Oct 20082:17 pmRNSHolding(s) in Company
20th Oct 200812:52 pmRNSDirector/PDMR Shareholding
17th Oct 20087:30 amRNSResponse to share price movement
13th Oct 200810:04 amRNSHolding(s) in Company
9th Oct 200810:09 amRNSHolding(s) in Company
19th Sep 200812:07 pmRNSHolding(s) in Company
16th Sep 20082:52 pmRNSDirector/PDMR Shareholding
4th Sep 20087:00 amRNSInterim Results
29th Aug 20083:45 pmRNSNotice of Results
26th Aug 20083:58 pmRNSHolding(s) in Company
30th Jul 200812:01 pmRNSHolding(s) in Company
29th Jul 20082:29 pmRNSHolding(s) in Company
15th Jul 20082:00 pmRNSRe Agreement
25th Jun 20087:00 amRNSDirector/PDMR Shareholding
2nd Jun 20087:19 amRNSDirectorate Change
15th Apr 20082:58 pmRNSDirector/PDMR Shareholding
15th Apr 200812:46 pmRNSPreliminary Results
10th Apr 20089:05 amRNSNotice of Results
4th Apr 20083:49 pmRNSHolding(s) in Company
3rd Apr 200812:47 pmRNSDirectorate Change
20th Mar 20084:24 pmRNSHolding(s) in Company
20th Mar 20084:19 pmRNSHolding(s) in Company-Amend
19th Mar 20084:00 pmRNSTotal Voting Rights
18th Mar 20082:49 pmRNSHolding(s) in Company
11th Mar 20085:43 pmRNSDirector Details
25th Feb 20082:41 pmRNSHolding(s) in Company
8th Feb 20087:30 amRNSDirector Declaration
8th Feb 20087:00 amRNSBoard and Adviser Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.